TMD — Titan Medical Balance Sheet
0.000.00%
Last trade - 00:00
- CA$5.70m
- -CA$0.47m
- $17.63m
- 41
- 99
- 11
- 48
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Cash and Short Term Investments | 0.814 | 25.5 | 32.3 | 3.29 | 7.54 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0.084 | 0.072 | 8.28 | 0 | — |
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 1.75 | 26.9 | 43.7 | 5.04 | 8.66 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 0.03 | 1.11 | 1.64 | 0 | — |
Net Intangible Assets | |||||
Long Term Notes Receivable | |||||
Total Assets | 3.38 | 29.8 | 47.2 | 7.12 | 8.76 |
Payable / Accrued | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 15.1 | 42.9 | 10.9 | 8.96 | 3.12 |
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Liabilities | 15.1 | 43.6 | 11.9 | 10.3 | 3.98 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | -11.7 | -13.8 | 35.3 | -3.16 | 4.79 |
Total Liabilities & Shareholders' Equity | 3.38 | 29.8 | 47.2 | 7.12 | 8.76 |
Total Common Shares Outstanding |